Since the combination of these five anti-CD4 binding site VHH neutralized 100% of strains tested with an IC50 of less than 0.2 μg/ml (Fig. 4), their combined use in a topical anti-HIV microbicide [28] could provide a higher barrier to infection and viral escape than the use of any one VHH individually. Here, CD4 is linked to infection.